PROGNOSTIC PERFORMANCE OF CLINICAL RISK SCORES IN FOLLICULAR LYMPHOMA: EVALUATION IN A SINGLE-CENTER SERIES

EHA Library, Pablo Mozas, 324245

COASTAL: A PHASE 3 STUDY OF THE PI3KΔ INHIBITOR ZANDELISIB WITH RITUXIMAB (R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN’S LYMPHOMA (INHL)

EHA Library, Wojciech Jurczak, 324246

A PHASE 2 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE VERSUS IDELALISIB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (LOTIS-6)

EHA Library, Carmelo Carlo-Stella, 324247

CLINICAL OUTCOMES IN PATIENTS RELAPSED/REFRACTORY AFTER ≥ 2 PRIOR LINES OF THERAPY FOR FOLLICULAR LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

EHA Library, Steve Kanters, 324248

PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL): INMIND

EHA Library, Christian W. Scholz, 324249

OUTCOMES OF BENDAMUSTINE + RITUXIMAB FIRST-LINE THERAPY IN PATIENTS WITH INDOLENT NON-HODGKIN’S LYMPHOMA OR MANTLE CELL LYMPHOMA: REAL WORLD EXPERIENCE

EHA Library, Rouslan Kotchetkov, 324250

ASSOCIATION OF DISEASE HISTORY DURATION AND SURVIVAL RATES IN FOLLICULAR LYMPHOMA PATIENTS AS A NEW FACTOR OF UNFAVORABLE PROGNOSIS.

EHA Library, Sergey Kravchenko, 324251

TOWARDS PERSONALIZED MEDICINE FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA PATIENTS: THE CANTERA LUPIAE REGISTRY

EHA Library, Sanne Tonino, 324252

CONVENTIONAL INTERVENTIONS FAILED TO PROVIDE SURVIVAL BENEFIT FOR EARLY-STAGE MAJOR SALIVARY GLAND MARGINAL ZONE LYMPHOMA

EHA Library, Lei Fan, 324253

EARLY STAGE FOLLICULAR LYMPHOMA: A CURABLE DISEASE? LONG-TERM FOLLOW-UP FROM A SINGLE UNIT.

EHA Library, Stavrianna Diavati, 324254

HAIRY CELL LEUKEMIA: SINGLE CENTER EXPERIENCE

EHA Library, Ziad Emarah, 324255

MYD88 MUTATION IN WALDENSTROMSÖM MACROGLOBULINEMIA AND TREATMENT OUTCOME. A SINGLE CENTRE EXPERIENCE

EHA Library, Aiste Konenko, 324256

RETROSPECTIVE STUDY ON MANTLE CELL LYMPHOMA (MCL) AND TREATMENT OUT-COME- A SINGLE CENTER EXPERIENCE.

EHA Library, Ezzat Elhassadi, 324257

PEGFILGRASTIM IN THE SUPPORTIVE CARE OF HEAVILY PRETREATED MULTIPLE MYELOMA IN POMALIDOMIDE-BASED TREATMENT

EHA Library, Claudio Cerchione, 324258

PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN THE DETERMINATION OF SEVERE PROGNOSIS OF HEMATOLOGICAL PATIENTS WITH COVID-19 INFECTION. DATA OF MOLDOVAN HEMATOLOGICAL CENTER.

EHA Library, Victor Tomacinschii, 324259

COVID-19 OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A SINGLE CENTER EXPERIENCE

EHA Library, Nikolaos Spyridis, 324260

SARS-COV-2 INFECTION IN HAEMATOLOGICAL PATIENTS: DESCRIPTIVE COHORT STUDY OF HOSPITALIZED PATIENTS IN A TERTIARY CARE CENTER

EHA Library, Ana María Hoyos Brea, 324261

CLINICAL CHARCTERISTICS AND RISK FACTORS OF SEVERITY OF COVID19 INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Rym El Fatmi, 324262

BACTEREMIA IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES

EHA Library, BECHIR ACHOUR, 324263

INCIDENCE OF CELL-MEDIATED IMMUNODEFICIENCY-RELATED INFECTIOUS DISEASES IN THE HEMATOLOGIC DEPARTMENT OF A COMMUNITY HOSPITAL: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS

EHA Library, Naoto Imoto, 324264

REAL-WORLD GLUCARPIDASE UTILIZATION IN MALIGNANT HEMATOLOGY PATIENTS RECEIVING HIGH-DOSE METHOTREXATE: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Julio Chavez, 324265

HEPATITIS B AND C IN ACUTE LYMPHOBLASTIC LEUKEMIAA 2-YEAR STUDY 2015-2016 AT CHILDREN WELFARE TEACHING HOSPITAL

EHA Library, Hasanein Ghali, 324266

ETIOLOGICAL CHARACTERISTICS OF BLOODSTREAM INFECTION PATOGENS IN PATIENT WITH ACUTE MYELOID LEUKEMIA

EHA Library, Maryna Tsiarentsyeva, 324267

A SCORING SYSTEM FOR PREDICTING THE PROGNOSIS OF LATE-ONSET SEVERE PNEUMONIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Le-Qing Cao, 324268

GEOTRICHUM CAPITATUM SEPTICEMIA IN NEUTOPENIC PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Imen Ben Amor, 324269

A NOVEL PREDICTIVE SCORING MODEL FOR PREDICTING INFECTION

EHA Library, Mei Hong, 324270

NEXT-GENERATION SEQUENCING RAPIDLY IDENTIFY PATHOGENIC MICROBE IN BRONCHOALVEOLAR LAVAGE LIQUID OBTAINED FROM PATIENTS FAILED MULTIPLE LINES OF EMPIRICAL ANTI-MICROBIAL TREATMENT

EHA Library, xm fei, 324271

REVIEW OF ANTIFUNGAL PROPHYLAXIS PRACTICES AND INCIDENCE OF BREATHROUGH FUNGAL INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

EHA Library, Jessica Muscat, 324272

THROMBOELASTOMETRY AND CONVENTIONAL COAGULATION TESTS AS PREDICTORS OF PROGRESSION TO CRITICAL PHASE IN PATIENTS IN THE FEBRILE PHASE OF DENGUE FEVER: A PRELIMINARY PROSPECTIVE CASE CONTROL STUDY

EHA Library, Ahalyaa Sivashangar, 324273

COVID-19 AND MALIGNANT HEMOPATHIES: EXPERIENCE OF THE CLINICAL HEMATOLOGY SERVICE OF THE UNIVERSITY HOSPITAL CENTER IBN SINA IN RABAT

EHA Library, hajar khibri, 324274

HEMATOLOGIC PARAMETERS IN ASYMPTOMATIC PATIENTS WITH ACTIVE COVID-19 INFECTION.

EHA Library, Mounir Ababou, 324275

BENEFIT OF TREATMENT WITH TOCILIZUMAB IN HEMOPHAGOCYTIC LYMPHYSTIOCYTOSIS SECONDARY TO VISCERAL LEISHMANIASIS INFECTION.

EHA Library, María Elena Cornejo Calvo , 324276

INFECTION PROFILE AND OUTCOMES OF ADULT ACUTE LEUKEMIA PATIENTS DEVELOPING CHEMOTHERAPY-ASSOCIATED FEBRILE NEUTROPENIA AT THE PHILIPPINE GENERAL HOSPITAL

EHA Library, Camille Ariadne Tanchanco, 324277

SET UP OF A GENE PANEL FOR NEXT GENERATION SEQUENCING IN THE CAUSES OF ERYTHROCYTOSIS

EHA Library, Andrea Benetti, 324278

IMPACT OF THE COVID-19 PANDEMIC IN THE MR AVAILABILITY FOR IRON OVERLOADED PATIENTS

EHA Library, Antonella Meloni, 324279

PROSPECTIVE ANALYSIS OF DIFFERENT ORAL IRON POSOLOGY ON CLINICAL FINDINGS AND SERUM IRON PARAMETERS INCLUDING HEPCIDIN IN PATIENTS WITH IRON DEFICIENCY ANEMIA

EHA Library, Meltem Kurt Yüksel, 324280

THROMBOCYTOPENIA AS AN INITIAL FINDING IN IRON DEFICIENCY ANEMIA

EHA Library, Espen Arnesen Winsnes, 324281

THE ANALYSIS OF THE FIRST HEMATOLOGICAL CONSULTATIONS IN CROATIAN HEMATOLOGY OUTPATIENT CLINICS - A KROHEM STUDY

EHA Library, Marijo Vodanovic, 324282

AGE AND IRON STATUS IN PATIENTS WITH HFE MUTATIONS AT FIRST TIME REFERRAL TO PHLEBOTOMY

EHA Library, Miriam Sandnes, 324283

HYPERFERRITINEMIA IN HETEROZYGOUS H63D AND HYPERTRIGLYCERIDEMIA

EHA Library, Maria Angustias Molina-Arrebola, 324284

EXTRAVASATION OF INTRAVENOUS IRON INFUSION։ A CASE REPORT

EHA Library, Evaggelia Vetsiou, 324285

THIAMINE REVERSAL OF LACTIC ACIDOSIS IN HIGH BURDEN HEMATOLOGICAL MALIGNANCY: CASE SERIES

EHA Library, Kamal Alzahrani, 324286

CLONALITY ANALYSIS IN FOLLOW-UP OF PATIENTS WITH NON-HODGKIN LYMPHOMA

EHA Library, Ira Koković, 324287

TUMOR-NONSPECIFIC METHYLATION OF THE MIR-145 GENE IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Voropaeva, 324288

COMBINING FLOW CYTOMETRY AND MOLECULAR GENETICS FOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME

EHA Library, Nikolai Tcvetkov, 324289

SUPPRESSION OF AKR1B1 REDUCES CELL PROLIFERATION AND ENHANCES SENSITIVITY TO HYPOMETHYLATING AGENTS BY INHIBITING MTORC1 SIGNALING PATHWAY IN HIGH-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Hongyan Tong, 324290

U2AF1 MUTATION PROMOTES TUMORIGENICITY THROUGH FACILITATING AUTOPHAGY FLUX MEDIATED BY FOXO3A ACTIVATION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Lingyun Wu, 324291

THE UTILITY AND OUTCOME OF NEXT GENERATION SEQUENCING IN THE DIAGNOSTIC WORK UP OF PATIENTS WITH UNEXPLAINED CYTOPENIA AT A PRIMARY REFERRAL CENTER

EHA Library, Dicte Træden, 324292

MUTATIONAL PROFILE AND IMMUNOPHENOTYPIC CHANGES IN BONE MARROW COMPARTMENTS OF CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS

EHA Library, João Gaião Santos, 324293

AKT KINASE REGULATES TIM-3 EXPRESSION IN MYELOID NEOPLASMS

EHA Library, Anna Parfenenkova, 324294

POLYMORPHISM OF GSTM1, GSTT1 AND CYTOKINE GENES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Zhanna Sidorova, 324295

A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS EPOETIN ALFA FOR THE TREATMENT OF ANEMIA DUE TO LOWER-RISK MDS IN ESA-NAIVE PATIENTS REQUIRING RBC TRANSFUSIONS (THE COMMANDS TRIAL)

EHA Library, Matteo Della Porta, 324296

MUTATIONAL ANALYSIS IN LOW RISK MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER REPORT

EHA Library, Giulio Cassanello, 324298

MAGROLIMAB + AZACITIDINE VERSUS AZACITIDINE + PLACEBO IN UNTREATED, HIGHER-RISK (HR) MYELODYSPLASTIC SYNDROME: THE PHASE 3, RANDOMIZED, ENHANCE STUDY

EHA Library, Guillermo Garcia-Manero, 324299

TREATMENTS AND OUTCOMES FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) BY REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-R) SCORES AT THE HUNTSMAN CANCER INSTITUTE

EHA Library, Connor Willis, 324300

A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY OF INCB000928 MONOTHERAPY IN PATIENTS WITH ANEMIA DUE TO MYELODYSPLASTIC SYNDROMES OR MULTIPLE MYELOMA

EHA Library, Jean-Marie Michot, 324301

SWITCHING TO AN ALTERNATIVE RECOMBINANT ERYTHROPOIETIN AGENT MAY BE EFFECTIVE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Bruno Fattizzo, 324302

A CLINICAL STUDY ON MYELODYSPLASTIC SYNDROMES

EHA Library, Adela Perolla, 324303

ALLOGENEIC STEM CELL TRANSPLANTATION IN 34 PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Malek Benakli, 324304

UNRAVELLING RESISTANCE MECHANISMS TO PROTEASOME INHIBITORS IN MULTIPLE MYELOMA

EHA Library, Carolina Afonso, 324305

EFFECTS OF DARATUMUMAB(DARA), CYCLOPHOSPHAMIDE (C), THALIDOMIDE (T) AND DEXAMETHASONE (D) COMBINATION ON LYMPHOCYTE POPULATIONS OF TRANSPLANT ELIGIBLE NEWLY DIAGNOSE MULTIPLE MYELOMA PATIENTS

EHA Library, Allan Santos, 324306

ROLE OF PROTEIN KINASE CK1 ALPHA AND LENALIDOMIDE IN THE INTERACTIONS BETWEEN MULTIPLE MYELOMA PLASMA CELLS AND BONE MARROW STROMAL CELLS: THERAPEUTIC IMPLICATIONS

EHA Library, Anna Fregnani, 324307

THE FIRST MYELOMA PATIENT DERIVED XENOGRAFT FROM TREATMENT REFRACTORY HUMAN MYELOMA CELLS IN SWEDEN AND THE EFFECT OF BROMODOMAIN-INHIBITORS ON MYELOMA CELLS IN VIVO

EHA Library, David Jansson, 324308

CYTOKINE GENE POLYMORPHISMS AND AUTOLOGICAL TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Svetlana Svitina, 324309

THE POTENTIAL DIAGNOSTIC ROLE OF CD138+/BCMA+/CD319+ MICROPARTICLES FROM THE PLASMA CELL IN MULTIPLE MYELOMA CLINICAL MONITORING BY FLOW CYTOMETRY

EHA Library, Zhaoyun Liu, 324310

GLOBAL DNA METHYLATION AND PROMOTER GENE METHYLATION IN MGUS AND DIFFERENT STAGES OF MULTIPLE MYELOMA

EHA Library, Pavla Flodrova, 324311

PROGNOSTIC ROLE OF MONOMERIC C-REACTIVE PROTEIN IN NEWLY DIAGNOSED MULTIPLE MYELOMA AS A MARKER OF THE BONE LOSS DEGREE

EHA Library, Sergey Semochkin, 324312

VALIDATION OF ALGORITHMS TO IDENTIFY FIRST-LINE THERAPY (INDUCTION AND MAINTENANCE) FOR MULTIPLE MYELOMA FOR USE IN ELECTRONIC HEALTHCARE DATABASES

EHA Library, Ariel Berger, 324313

COMPARISON OF THE EXPRESSION PROFILE AND PROMOTER GENE METHYLATION OF SELECTED TUMOR-SUPPRESSOR GENES IN MYELOMA CELLS

EHA Library, Katerina Smesny Trtkova, 324314

EFFICACY AND SAFETY OF VENETOCLAX COMBINATIONS IN T(11;14) MULTIPLE MYELOMA: REAL WORLD DATA OF 50 PATIENTS COLLECTED FROM 7 HUNGARIAN CENTERS

EHA Library, Virág Szita, 324315

FIRST CASE OF SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS TREATED WITH ANTI-B CELL MATURATION ANTIGEN -CAR T CELLS

EHA Library, Aina Oliver Caldés, 324316

OUTCOMES OF DARATUMUMAB-CONTAINING REGIMENS IN THE TREATMENT OF RELAPSED MULTIPLE MYELOMA: REAL-WORLD DATA FROM THE CANADIAN MYELOMA RESEARCH GROUP DATABASE

EHA Library, Richard LeBlanc, 324317

THE NATURAL HISTORY OF SYSTEMIC AL AMYLOIDOSIS FOLLOWING UPFRONT TREATMENT WITH BORTEZOMIB: AN ANALYSIS OF REAL-WORLD LONGITUDINAL DATA

EHA Library, Sriram Ravichandran, 324318

A CLINICAL-DECISION TOOL TO IMPROVE THE STRATEGY OF MULTIPLE MYELOMA TREATMENT

EHA Library, Alexander Luchinin, 324319

IN-CLASS TRANSITION FROM INTRAVENOUS TO ORAL PROTEASOME INHIBITOR AS LONG PROTEASOME INHIBITION IN NEWLY DIAGNOSED AND FIRST RELAPSED MULTIPLE MYELOMA PATIENTS IN CHINA: A REAL-WORLD STUDY

EHA Library, Wenming Chen, 324320

EFFICACY AND SAFETY OF INDUCTION THERAPY WITH IAD VERSUS IRD REGIMEN IN FRAGILE ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA-RESULTS OF PROSPECTIVE MULTICENTER CLINICAL TRAIL

EHA Library, Li Bao, 324321

RISK ASSESSMENT MODEL FOR IMMUNOMODULATORY DRUG-ASSOCIATED VENOUS THROMBOSIS AMONG PATIENTS WITH MULTIPLE MYELOMA IN CHINA

EHA Library, Juan Li, 324322

REAL-LIFE DATA ON THE SAFETY AND EFFICACY OF CARFILZOMIB AND LENALIDOMIDE PLUS DEXAMETHASONE (KRD) IN 149 PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS OF GEMMAC GROUP.

EHA Library, Antonio Garcia-Guiñon, 324323

HIGH LEVELS OF GALECTIN-3 AND IMMUNOGLOBULIN LIGHT CHAINS AS MARKERS OF THE RISK OF PROGRESSION OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE IN RESIDENTS OF GOMEL REGION OF BELARUS

EHA Library, Zhanna Kozich, 324324

ANALYSIS OF DELAY IN THE DIAGNOSIS OF MULTIPLE MYELOMA IN A SANITARY REGION OF SOUTHERN SPAIN.

EHA Library, Leire Sanz Rekalde, 324325

REAL-WORLD EVIDENCE OF CARFILZOMIB USE AMONG MULTIPLE MYELOMA PATIENTS WITH AT LEAST ONE PRIOR THERAPY ACROSS 4 COUNTRIES IN CENTRAL EASTERN EUROPE AND ISRAEL

EHA Library, Yael Cohen, 324326

MODIFIED DELPHI CONSENSUS ON THE RELEVANCE OF MINIMAL RESIDUAL TESTING IN MULTIPLE MYELOMA IN THE CLINICAL PRACTICE

EHA Library, Karthik Ramasamy, 324327

A RETROSPECTIVE TWO-CENTRE COHORT STUDY OF THE EFFICACY AND SAFETY OF DARATUMUMAB WITH BORTEZOMIB AND DEXAMETHASONE THERAPY FOR PREVIOUSLY TREATED MULTIPLE MYELOMA

EHA Library, IRENE SANCHEZ PRIETO, 324328

LIGHTHOUSE (OP-108): A PHASE 3 STUDY OF MELFLUFEN IN COMBINATION WITH DEXAMETHASONE AND DARATUMUMAB VS DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, María-Victoria Mateos, 324329

WHOLE BODY MRI IS A FEASIBLE AND COST-EFFECTIVE IMAGING MODALITY FOR WORK-UP OF SUSPECTED OR NEWLY DIAGNOSED MULTIPLE MEYLOMA: A RETROSPECTIVE, SINGLE CENTRE COHORT STUDY

EHA Library, Richard Buka, 324330

AL AMYLOIDOSIS SURVIVAL EVOLUTION IN NEW AGENTS ERA : A REAL LIFE EXPERIENCE

EHA Library, Ornella Rizzo, 324331

RECOMMENDATIONS FOR VACCINATION GIVEN TO PATIENTS WITH MULTIPLE MYELOMA IN REAL-WORLD CLINICAL PRACTICE AND PATIENTS` COMPLIANCE WITH THEM

EHA Library, Heinz Ludwig, 324332

COVID-19 MORTALITY IN CONCURRENT MULTIPLE MYELOMA (MM) – A PROSPECTIVE AND COMPARATIVE CASE SERIES THROUGH THE FIRST AND SECOND WAVE OF THE SARS-COV-2 PANDEMIC IN A UK TERTIARY HAEMATOLOGY CENTRE

EHA Library, Sammy Shaya, 324333

CARFILZOMIB USE AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE ASIA PACIFIC REGION: AN INTERIM ANALYSIS FROM A PROSPECTIVE, REAL-WORLD STUDY

EHA Library, Hang Quach, 324334

BCMA-DIRECTED THERAPY IN MULTIPLE MYELOMA: EFFECT OF ONLINE EDUCATION ON CLINICIAN KNOWLEDGE AND CONFIDENCE

EHA Library, Amanda Taylor, 324335

A DESCRIPTIVE COST-ANALYSIS OF MYX.1/MCRN003 - A PHASE 2 CLINICAL TRIAL EVALUATING HIGH-DOSE WEEKLY CARFILZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Bethany Monteith, 324336

RACIAL DISPARITIES OF OUTCOME IN MULTIPLE MYELOMA COMPARATIVE ANALYSIS OF VARIED ETHNIC GROUPS IN GALILEE, ISRAEL

EHA Library, Najib Dally, 324337

TREATMENT FOR NEWLY DIAGNOSED, FIT AND YOUNG PATIENTS WITH MULTIPLE MYELOMA: 'ONE SIZE FITS ALL’’ OR PERSONALIZED TREATMENT APPROACHES SHOULD BE CONSIDERED?

EHA Library, Fatema Abbas, 324338

MULTIPLE MYELOMA TREATMENT DECISIONS FROM THE PATIENT PERSPECTIVE

EHA Library, Matthew Lyall, 324339

BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (VRD) AS FIRST LINE THERAPY IN MULTIPLE MYELOMA PATIENTS. REAL LIFE EXPERIENCE IN A SINGLE INSTITUTION.

EHA Library, Dunia De Miguel Llorente, 324340

THE IMPACT OF COVID-19 ON PATIENT DISEASE EXPERIENCE: INSIGHTS FROM SOCIAL MEDIA POSTS CONTRIBUTED BY PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Rebecca Crawford, 324341

THE PATIENT EXPERIENCE OF MULTIPLE MYELOMA: SYMPTOMS AND HEALTH-RELATED QUALITY OF LIFE

EHA Library, Courtney Levy, 324342

PHASE 2 MARCH STUDY OF ORAL ATG-010 PLUS LOW DOSE DEXAMETHASONE IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PREVIOUSLY EXPOSED TO AN IMMUNOMODULATORY AGENT AND A PROTEASOME INHIBITOR

EHA Library, Weijun Fu, 324343

VALIDATION OF THE MYRADS REPORTING CRITERIA USING DATA FROM A PROSPECTIVE IMAGING STUDY IN PLASMA CELL DYSCRASIAS (LOOMIS).

EHA Library, Guido Nador, 324344

REDEFINING OUTCOMES IN MULTIPLE MYELOMA IN COVID-19 INFECTED PATIENTS. RECONSIDERING THE THROMBOSIS AND INFECTIVE RISK.

EHA Library, Harberth Fernandez-Leyva, 324345